Blood pressure medication recall expands over cancer risk  SlashGear

The FDA has announced that Teva Pharmaceuticals USA is expanding its voluntary recall of high blood pressure medication losartan potassium. The recall ...

View full coverage on Google News
The FDA has announced that Teva Pharmaceuticals USA is expanding its voluntary recall of high blood pressure medication losartan potassium. The recall startedThe FDA has announced that Teva Pharmaceuticals USA is expanding its voluntary recall of high blood pressure medication losartan potassium. The recall started on April 25 in the US, and has now bee…

Blood pressure medication recall expands over cancer risk - SlashGear

The new recall of six lots brings the total to 41 lots of bulk losartan potassium sold to Golden State Medical Supply of California.The new recall of six lots brings the total to 41 lots of bulk losartan potassium sold to Golden State Medical Supply of California.

Teva Pharmaceuticals Expands Patient-Level Losartan Recall

The expanded recall includes six lots of bulk losartan potassium tabletsThe expanded recall includes six lots of bulk losartan potassium tablets

Another recall expansion for some blood pressure medication | WKBN

Teva Pharmaceuticals USA, Inc. has expanded its voluntary consumer-level recall originally initiated on April 25, 2019 in the United States of losartan potassium tablets.Teva Pharmaceuticals USA, Inc. has expanded its voluntary consumer-level recall originally initiated on April 25, 2019 in the United States of losartan potassium tablets. This is due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – that is above the US Food & Drug Administration’s interim acceptable exposure limit.

Blood pressure medication recall expanded due to cancer risk | fox8.com

The FDA increased inspections of foreign drugmakers. Problems remain at Chinese and Indian plants that made blood pressure meds recalled for cancer risk.The FDA increased inspections of foreign drugmakers. Problems remain at Chinese and Indian plants that made blood pressure meds recalled for cancer risk.

Blood pressure drug recall: FDA investigates plants that made meds

The FDA has added 80 lots of Amlodipine Valsartan blood pressure medication to the hypertension drug recall list that continues to grow.Aurobindo Pharma USA recalls lots of valsartan, amlodipine-valsartan, and valsartan-hydrochlorothiazide tablets. 

FDA Adds Amlodipine Valsartan To Blood Pressure Drug Recall | Fortune

Blood Pressure Drug Recall List Expands to Include More Valsartan Tablets

Blood Pressure Drug Recall List Expands to Include More Valsartan Tablets

Teva Pharmaceuticals has expanded its initial recall of losartan potassium tablets to include another six lots for a cancer-causing impurity.Teva Pharmaceuticals has expanded its initial recall of losartan potassium tablets to include another six lots for a cancer-causing impurity.

Blood Pressure Medication Recall 2019: Expanded Recall Issued For Cancer-Causing Impurity

Teva Pharmaceuticals has expanded its recall of blood pressure and heart medicine by discontinuing sales of certain 50 mg and 100 mg strength losartan potassium USP Tablets, according to the U.S.Teva Pharmaceuticals has expanded its recall of blood pressure and heart medicine by discontinuing sales of certain 50 mg and 100 mg strength losartan potassium USP Tablets, according to the U.S.

Teva Pharmaceuticals Widens Recall on Blood Pressure Medication - NBC10 Boston